The license encompasses both a novel method and bioinformatic tools that combine to improve the level of detection in NGS, allowing for the identification of ultrarare gene variants.
Read More
Using the kit, clinicians can accurately and reproducibly monitor residual disease in patients with chronic myeloid leukemia, even at low levels.
Read More
Continued validation of Lophius’ development capabilities bodes well as the company advances into tuberculosis diagnostics as its next focus area.
Read More
Clearance enables accurate and easy-to-interpret AML and MDS detection with reduced validation burden.
Read More
With three NCI grants, BioFluidica is investigating chip-based liquid biopsy technologies for the detection of cancer and related genetic variants.
Read More